Compounding Pharmacy Compliance Year-End Update 2026: Your Essential Guide to Navigating the Evolving Regulatory Landscape
December 9-10, 2026 | W Hotel, Philadelphia, PA
The Compounding Pharmacy Compliance Year-End Update returns for 2026, offering an in-depth exploration of critical compliance areas and strategies to ensure inspection readiness in an increasingly complex regulatory environment. As USP regulations and FDA oversight continue to evolve, staying informed is essential to maintaining high-quality compounding standards, improving patient safety, and ensuring compliance. This conference is specifically designed to help compounding professionals navigate regulatory updates, address compliance challenges, and optimize operational practices for both 503A and 503B facilities.
What’s New in 2026?
This year’s program features 2 days of live content from 30+ industry thought leaders, live speaker Q&A sessions, breakout discussions, and on-demand content. With perspectives from Empower Pharmacy, Strive Pharmacy, Alliance for Pharmacy Compounding, Wells Pharmacy Network, Preston’s Pharmacy, Fallon Wellness Pharmacy, Revelation Pharma, The Art of Medicine Compounding Facility, Blend, Vios Compounding, Curexa Pharmacy, Americare Pharmaceutical Services, Mixlab, Drug Crafters Pharmacy, Noom, and more, this event is not to be missed.
This year’s program includes advanced insights from expert perspectives, including the opportunity to:
- Hear case studies directly from compounding thought leaders on navigating the latest regulatory updates and implementing streamlined operational strategies to ensure quality
- Deep dive into a comprehensive range of hot topics covering all aspects of compounding compliance, including: operationalizing USP updates, analyzing current audits and 483s, lessons learned from the GLP-1 landscape, managing drug shortages compliantly, ensuring inspection readiness, regulatory considerations for AI in compounding, and more
- Learn crucial perspectives from Empower Pharmacy, Strive Pharmacy, Wells Pharmacy Network, Preston’s Pharmacy, Fallon Wellness Pharmacy, Vios Compounding, Curexa Pharmacy, Americare Pharmaceutical Services, Mixlab, Drug Crafters Pharmacy, Noom, and more
- Network in-person with colleagues and counterparts to expand your network and establish powerful partnerships
Choose Your Learning Path with Tracked Programming
503A Track
- Navigating USP regulatory adherence and 503A-specific implementation strategies
- Managing drug shortages with compliance strategies for 503A pharmacies
- Mastering state board 503A requirements and enhancing inspection readiness
- Structuring compliant partnerships across telehealth and med spa channels
503B Track
- Examining the 503B regulatory landscape and recent industry updates
- Mastering drug shortages with regulatory and operational strategies for 503Bs
- Best practices in 503B quality assurance to ensure cGMP compliance
- Strategic considerations for transitioning from 503A to 503B
Featured Speakers Include:
- Scott Brunner, Chief Executive Officer, Alliance for Pharmacy Compounding
- Edgar Gonzalez, General Counsel & Chief Compliance Officer, Empower Pharmacy
- Melissa Stefko, Senior Vice President of Regulatory Affairs, Wells Pharmacy Network
- Timothy Fensky, Board Member, Massachusetts Board of Registration in Pharmacy
- Scott Welch, Co-Owner & Pharmacist-In-Charge, Preston’s Pharmacy
- Erika Fallon, Pharmacist and Owner, Fallon Wellness Pharmacy
- Jamal Almustapha, Vice President of Quality, Strive Pharmacy
- Victor Hill, Director of Quality, Vios Compounding
- Vinnie Dam, Founder/Chief Pharmacy Officer, Mixlab
- Lawrence Rossetti, Chief Executive Officer, Drug Crafters Pharmacy
- Norman Petty, General Counsel and EVP, Business Affairs, Noom
And many more industry experts!
ACPE Credits for Pharmacists: Pending Approval
For full program details and to register for you and your team, visit:
https://informaconnect.com/compounding-pharmacy-compliance-year-end/.
